Notice of Intent to Sole Source – Roche Diagnostics BenchMark ULTRA Reagents & Consumables

This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. This procurement is for a one-year (09/01/2026 – 08/31/2027) contract for Roche Ventana BenchMark ULTRA reagents, consumables, service for immunohistochemistry (IHC) and in-situ hybridization (ISH) testing. This purchasing agreement is needed to maintain clinically relevant patient testing with Roche branded IHC and ISH materials to meet the need of the DLM’s Hematology Bone Marrow Pathology and Consultation Service. This acquisition is being conducted using policies unique to the Federal Acquisition Regulation (FAR) Part 13 –Simplified Acquisition Procedures, Subpart 13.106-1(b)(1), For purchases not exceeding the simplified acquisition threshold (SAT), contracting officers may solicit from one source if the contracting officer determines that the circumstance of the contract action deem only one source reasonably available. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements. Comments to this announcement, referencing this posting number, may be submitted to the NIH, Clinical Center, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, to the attention of Ryssa Nix, Contract Specialist via email to Ryssa.nix@nih.gov by close date. Notice Type: Notice of Intent NAICS Code: 541690 PSC Code: 6550 Posted Date: 08/11/2026 Close Date: 08/23/2026 12pm EST End User IC: Clinical Center POC Name: Ryssa Nix Email Address: Ryssa.nix@nih.gov

• NAICS541690
• PSC6550

• NOI to sole source under SAT.docx

  .docx22 KB
  Download

• Chris Ryssa Nix
  ryssa.nix@nih.gov